Table 4.

Evaluation of general quality of life using the SF-36 of the 2 groups at different times. Values are mean (SD) unless otherwise specified.

Domains of SF-36Intervention Group, n = 35Control Group, n = 35p Intergroup**
T0T6T12T24T0T6T12T24
Bodily pain58.5 (26.3)62.7 (21.0)65.0 (22.6)60.8 (19.2)54.4 (23.2)61.5 (22.6)60.3 (22.5)57.9 (23.1)0.479
General health56.4 (23.7)54.0 (24.2)56.6 (23.1)54.3 (24.1)42.3 (21.4)6.9 (21.3)46.9 (22.9)47.2 (23.2)0.056
Mental health64.2 (25.5)68.1 (24.0)71.1 (21.6)69.5 (22.7)65.9 (22.0)67.2 (25.0)66.3 (22.0)69.7 (21.1)0.843
Physical functioning60.7 (20.8)61.0 (24.5)66.3 (19.8)*66.4 (20.9)57.9 (20.4)58.0 (18.4)62.4 (20.8)*58.7 (24.3)0.340
Role emotional57.0 (42.5)59.9 (42.6)58.0 (46.0)58.0 (44.6)54.2 (46.5)51.3 (43.8)54.1 (40.5)52.3 (45.9)0.541
Role physical53.6 (42.5)54.3 (40.4)57.9 (42.8)56.4 (43.4)45.0 (44.5)41.4 (38.8)47.9 (40.8)43.6 (44.7)0.177
Social aspects72.3 (28.2)73.0 (24.0)74.1 (24.4)71.9 (28.3)60.9 (25.9)69.4 (25.8)66.6 (26.8)67.3 (24.0)0.199
Vitality60.6 (23.8)61.3 (23.0)62.7 (24.1)63.3 (24.0)56.0 (20.8)57.6 (18.4)59.6 (21.7)57.7 (22.1)0.364
  • * p < 0.05 compared with T6.

  • ** ANOVA test.

  • SF-36: Medical Outcomes Study Short Form-36; T0: baseline assessment before randomization; T6: assessment 6 weeks after the start of the program; T12: assessment 12 weeks after the start of the program; T24: assessment 24 weeks after the start of the program.